These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 9949661
1. [Heparin therapy: 1998 (current use of the 80-year-old heparin)]. Rák K. Orv Hetil; 1999 Jan 10; 140(2):59-66. PubMed ID: 9949661 [Abstract] [Full Text] [Related]
5. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring. Hull RD, Pineo GF, Stein P. Int Angiol; 1998 Dec 10; 17(4):213-24. PubMed ID: 10204652 [Abstract] [Full Text] [Related]
6. Low molecular weight heparins: the optimal treatment for venous thromboembolism. Daskalopoulos ME, Daskalopoulou SS, Liapis CD. Curr Med Res Opin; 2004 Jul 10; 20(7):1001-5. PubMed ID: 15265244 [Abstract] [Full Text] [Related]
7. Heparin: from animal organ extract to designer drug. Middeldorp S. Thromb Res; 2008 Jul 10; 122(6):753-62. PubMed ID: 17996279 [Abstract] [Full Text] [Related]
8. Low-molecular-weight heparin in the treatment of pulmonary embolism. Ageno W, Turpie AG. Semin Vasc Surg; 2000 Sep 10; 13(3):189-93. PubMed ID: 11005462 [Abstract] [Full Text] [Related]
9. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins]. Lobato-Mendizábal E, Majluf-Cruz A. Rev Invest Clin; 2000 Sep 10; 52(5):529-45. PubMed ID: 11195182 [Abstract] [Full Text] [Related]
10. [Therapy of thromboses with low-molecular-weight heparins]. Haas S, Haas P. Wien Med Wochenschr; 1999 Sep 10; 149(2-4):39-45; discussion 45. PubMed ID: 10378321 [Abstract] [Full Text] [Related]
11. [Cost-effectiveness of the prevention of postoperative thromboembolism]. Bergqvist D, Mätzsch T. Orthopade; 1993 Apr 10; 22(2):140-3. PubMed ID: 8388560 [Abstract] [Full Text] [Related]
12. Heparin to pentasaccharide and beyond: the end is not in sight. Messmore HL, Wehrmacher WH, Coyne E, Fareed J. Semin Thromb Hemost; 2004 Feb 10; 30 Suppl 1():81-8. PubMed ID: 15085469 [Abstract] [Full Text] [Related]
14. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Couturaud F, Julian JA, Kearon C. Thromb Haemost; 2001 Oct 10; 86(4):980-4. PubMed ID: 11686355 [Abstract] [Full Text] [Related]
15. [Heparin-induced hemorrhage in the treatment of venous thromboembolism]. Monreal M, Casals A, Las Heras G, Roncalés J, Callejas JM, Martorell A, Lisbona C. Angiologia; 1990 Oct 10; 42(1):11-5. PubMed ID: 2321800 [Abstract] [Full Text] [Related]
17. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive? Hull RD, Pineo GF. Semin Thromb Hemost; 2004 Feb 10; 30 Suppl 1():11-23. PubMed ID: 15085462 [Abstract] [Full Text] [Related]
18. Current concepts of anticoagulation therapy. Hull RD, Pineo GF. Clin Chest Med; 1995 Jun 10; 16(2):269-80. PubMed ID: 7656539 [Abstract] [Full Text] [Related]
19. Are all low molecular weight heparins equivalent in the management of venous thromboembolism? Fareed J, Jeske W, Fareed D, Clark M, Wahi R, Adiguzel C, Hoppensteadt D. Clin Appl Thromb Hemost; 2008 Oct 10; 14(4):385-92. PubMed ID: 18815137 [Abstract] [Full Text] [Related]